参 考 文 献

　　1.Woffindin C，Hoenich NA.Blood-membrane interactions during haemodialysis with cellulose and synthetic membranes.Biomaterials，1988，9（1）：53-57

　　2.Henrich WL.Principles and practice of dialysis.4th ed.Lippincott：Williams & Wilkins，2009

　　3.Lee KB，Kim B，Lee YH，et al.Hemodialysis using heparin-bound Hemophan in patients at risk of bleeding.Nephron Clinical Practice，2004，97（1）：c5-c10

　　4.Chanard J，Lavaud S，Maheut H，et al.The clinical evaluation of low-dose heparin in haemodialysis：a prospective study using the heparin-coated AN69 ST membrane.Nephrology Dialysis Transplantation，2008，23（6）：2003-2009

　　5.Krieter DH，Fink E，Bonner G，et al.Anaphylactoid reactions during haemodialysis in sheep are associated with bradykinin release.Nephrol Dial Transplant，1995，10（4）：509-513

　　6.Desormeaux A，Moreau ME，Lepage Y，et al.The effect of electronegativity and angiotensin-converting enzyme inhibition on the kinin-forming capacity of polyacrylonitrile dialysis membranes.Biomaterials，2008，29（9）：1139-1146

　　7.Chenoweth DE，Cheung AK，Henderson LW.Anaphylatoxin formation during hemodialysis：effects of different dialyzer membranes.Kidney Int，1983，24（6）：764-769

　　8.Horl WH，Schaefer RM，Heidland A.Effect of different dialyzers on proteinases and proteinase inhibitors during hemodialysis.Am J Nephrol，1985，5（5）：320-326

　　9.Ansorge W，Pelger M，Dietrich W，et al.Ethylene oxide in dialyzer rinsing fluid：effect of rinsing technique，dialyzer storage time，and potting compound.Artif Organs，1987，11（2）：118-122

　　10.Marshall CP，Pearson FC，Sagona MA，et al.Reactions during hemodialysis caused by allergy to ethylene oxide gas sterilization.J Allergy Clin Immunol，1985，75（5）：563-567

　　11.Leong AS，Disney AP，Gove DW.Spallation and migration of silicone from blood-pump tubing in patients on hemodialysis.N Engl J Med，1982，306（3）：135-140

　　12.Clark WR，Hamburger RJ，Lysaght MJ.Effect of membrane composition and structure on solute removal and biocompatibility in hemodialysis.Kidney Int，1999，56（6）：2005-2015

　　13.Bonnardeaux A，Pichette V，Ouimet D，et al.Solute clearances with high dialysate flow rates and glucose absorption from the dialysate in continuous arteriovenous hemodialysis.Am J Kidney Dis，1992，19（1）：31-38

　　14.Morabito S，Pierucci A，Marinelli R，et al.Efficiency of different hollow-fiber hemofilters in continuous arteriovenous hemodiafiltration.Am J Nephrol，2000，20（2）：116-121

　　15.Swinford RD，Baid S，Pascual M.Dialysis membrane adsorption during CRRT.Am J Kidney Dis，1997，30（5 Suppl 4）：S32-S37

　　16.Clark WR，Macias WL，Molitoris BA，et al.Plasma protein adsorption to highly permeable hemodialysis membranes.Kidney Int，1995，48（2）：481-488

　　17.Vanholder R，Baurmeister U，Brunet P，et al.A bench to bedside view of uremic toxins.J Am Soc Nephrol，2008，19（5）：863-870

　　18.Gejyo F，Homma N，Suzuki Y，et al.Serum levels of beta 2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis.N Engl J Med，1986，314（9）：585-586

　　19.Yavuz A，Tetta C，Ersoy FF，et al.Reviews：Uremic Toxins：a new focus on an old subject.Semin Dial，2005，18（3）：203-211

　　20.Locatelli F，Martin-Malo A，Hannedouche T，et al.Effect of membrane permeability on survival of hemodialysis patients.J Am Soc Nephrol，2009，20（3）：645-654

　　21.Gejyo F，Narita I.Current clinical and pathogenetic understanding of beta 2-m amyloidosis in long-term haemodialysis patients.Nephrology，2003，8：S45-S49

　　22.Ronco C，Ricci Z，Bellomo R.Importance of increased ultrafiltration volume and impact on mortality：sepsis and cytokine story and the role for CVVH.EDTNA ERCA J，2002，Suppl 2：13-18

　　23.Swinford RD，Baid S，Pascual M.Dialysis membrane adsorption during CRRT.Am J Kidney Dis，1997，30（5 Suppl 4）：S32-S37

　　24.Chanard J，Lavaud S，Randoux C，et al.New insights in dialysis membrane biocompatibility：relevance of adsorption properties and heparin binding.Nephrol Dial Transplant，2003，18（2）：252-257

　　25.Hoenich NA，Woffindin C，Mathews JNS，et al.Biocompatibility of membranes used in the treatment of renal failure.Biomaterials，1995，16（8）：587-592

　　26.Sunohara T，Masuda T.Cellulose triacetate as a high-performance membrane.Contrib Nephrol，2011，173：156-163

　　27.Streicher E，Schneider H.The development of a polysulfone membrane.A new perspective in dialysis.Contrib Nephrol，1985，46：1-13

　　28.Bowry SK，Gatti E，Vienken J.Contribution of polysulfone membranes to the success of convective dialysis therapies.Contrib Nephrol，2011，173：110-118

　　29.Bowry SK.Dialysis membranes today.Int J Artif Organs，2002，25（5）：447-460

　　30.Henrie M，Ford C，Andersen M，et al.In vitro assessment of dialysis membrane as an endotoxin transfer barrier：geometry，morphology，and permeability.Artif Organs，2008，32（9）：701-710

　　31.Yamasaki H，Nagake Y，Makino H.Determination of bisphenol a in effluents of hemodialyzers.Nephron，2001，88（4）：376-378

　　32.Krieter DH，Canaud B，Lemke HD，et al.Bisphenol A in chronic kidney disease.Artif Organs，2013，37（3）：283-290

　　33.Krieter DH，Lemke HD.Polyethersulfone as a high-performance membrane.Contrib Nephrol，2011，173：130-136

　　34.Abe T，Kato K，Fujioka T，et al.The blood compatibilities of blood purification membranes and other materials developed in Japan.Int J Biomater，2011，2011：375390

　　35.Amore A，Bonaudo R，Ghigo D，et al.Enhanced production of nitric oxide by blood-dialysis membrane interaction.J Am Soc Nephrol，1995，6（4）：1278-1283

　　36.Pascual M，Schifferli JA，Pannatier JG，et al.Removal of complement factor D by adsorption on polymethylmethacrylate dialysis membranes.Nephrol Dial Transplant，1993，8（11）：1305-1306

　　37.Itoh S，Takeshita K，Susuki C，et al.Redistribution of P-selectin ligands on neutrophil cell membranes and the formation of platelet-neutrophil complex induced by hemodialysis membranes.Biomaterials，2008，29（21）：3084-3090

　　38.Sirolli V，Ballone E，Di Stante S，et al.Cell activation and cellular-cellular interactions during hemodialysis：effect of dialyzer membrane.Int J Artif Organs，2002，25（6）：529-537

　　39.Sato M，Morita H，Ema H，et al.Effect of different dialyzer membranes on cutaneous microcirculation during hemodialysis.Clin Nephrol，2006，66（6）：426-432

　　40.Haase M，Bellomo R，Morgera S，et al.High cut-off point membranes in septic acute renal failure：a systematic review.The International journal of artificial organs，2007，30（12）：1031

　　41.Gondouin B，Hutchison CA.High cut-off dialysis membranes：current uses and future potential.Adv Chronic Kidney Dis，2011，18（3）：180-187

　　42.Naka T，Haase M，Bellomo R.‘Super high-flux’or‘high cut-off’hemofiltration and hemodialysis.Contrib Nephrol，2010，166：181-189

　　43.Morgera S，Haase M，Kuss T，et al.Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure.Crit Care Med，2006，34（8）：2099-2104

　　44.Naka T，Haase M，Bellomo R.‘Super high-flux’or‘high cut-off’hemofiltration and hemodialysis.Contrib Nephrol，2010，166：181-189

　　45.Lee WC，Uchino S，Fealy N，et al.Super high flux hemodialysis at high dialysate flows：an ex vivo assessment.Int J Artif Organs，2004，27（1）：24-28

　　46.Hutchison CA，Bradwell AR，Cook M，et al.Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis.Clin J Am Soc Nephrol，2009，4（4）：745-754

　　47.Naka T，Jones D，Baldwin I，et al.Myoglobin clearance by super high-flux hemofiltration in a case of severe rhabdomyolysis：a case report.Crit Care，2005，9（2）：R90-R95

　　48.Nakatani T，Tsuchida K，Sugimura K，et al.Response of peripheral blood mononuclear cells in hemodialyzed patients against endotoxin and muramyldipeptide.Int J Mol Med，2002，10（4）：469-472

　　49.Nath KA.Renal response to repeated exposure to endotoxin：implications for acute kidney injury.Kidney Int，2007，71（6）：477-479

　　50.Lonnemann G.Chronic inflammation in hemodialysis：the role of contaminated dialysate.Blood Purif，2000，18（3）：214-223

　　51.Czermak P，Ebrahimi M，Catapano G.New generation ceramic membranes have the potential of removing endotoxins from dialysis water and dialysate.Int J Artif Organs，2005，28（7）：694-700

　　52.Jaber BL，Gonski JA，Cendoroglo M，et al.New polyether sulfone dialyzers attenuate passage of cytokineinducing substances from pseudomonas aeruginosa contaminated dialysate.Blood Purif，1998，16（4）：210-219

　　53.Takemoto Y，Nakatani T，Sugimura K，et al.Endotoxin adsorption of various dialysis membranes：in vitro study.Artificial organs，2003，27（12）：1134-1137

　　54.Maitz MF，Teichmann J，Sperling C，et al.Surface endotoxin contamination and hemocompatibility evaluation of materials.J Biomed Mater Res B Appl Biomater，2009，90（1）：18-25

　　55.Mares J，Thongboonkerd V，Tuma Z，et al.Specific adsorption of some complement activation proteins to polysulfone dialysis membranes during hemodialysis.Kidney Int，2009，76（4）：404-413

　　56.Opatrny KJ，Krouzzecky A，Polanska K，et al.Does an alteration of dialyzer design and geometry affect biocompatibility parameters？Hemodial Int，2006，10（2）：201-208

　　57.Boudville N，Horner M，McEwan E，et al.Effect of FX dialyzers on systemic inflammation and quality of life in chronic haemodialysis patients.Blood Purif，2009，27（2）：187-193

　　58.Yumoto M，Nishida O，Moriyama K，et al.In vitro evaluation of high mobility group box 1 protein removal with various membranes for continuous hemofiltration.Ther Apher Dial，2011，15（4）：385-393

　　59.Rimmele T，Assadi A，Cattenoz M，et al.High-volume haemofiltration with a new haemofiltration membrane having enhanced adsorption properties in septic pigs.Nephrol Dial Transplant，2009，24（2）：421-427

　　60.Modi GK，Pereira BJ，Jaber BL.Hemodialysis in acute renal failure：does the membrane matter？Semin Dial，2001，14（5）：318-321

　　61.Walker RJ，Sutherland WH，De Jong SA.Effect of changing from a cellulose acetate to a polysulphone dialysis membrane on protein oxidation and inflammation markers.Clin Nephrol，2004，61（3）：198-206

　　62.Itoh S，Susuki C，Tsuji T.Platelet activation through interaction with hemodialysis membranes induces neutrophils to produce reactive oxygen species.J Biomed Mater Res A，2006，77（2）：294-303

　　63.Alonso A，Lau J，Jaber BL.Biocompatible hemodialysis membranes for acute renal failure.Cochrane Database Syst Rev，2008（1）：D5283

　　64.Gastaldello K，Melot C，Kahn RJ，et al.Comparison of cellulose diacetate and polysulfone membranes in the outcome of acute renal failure.A prospective randomized study.Nephrol Dial Transplant，2000，15（2）：224-230

　　65.Honore PM，Jamez J，Wauthier M，et al.Prospective evaluation of short-term，high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock.Crit Care Med，2000，28（11）：3581-3587

　　66.Kumar VA，Craig M，Depner TA，et al.Extended daily dialysis：A new approach to renal replacement for acute renal failure in the intensive care unit.Am J Kidney Dis，2000，36（2）：294-300 连续性肾脏替代治疗